Host cell reorganization by SARS-CoV-2
- Funded by Canadian Institutes of Health Research (CIHR)
- Total publications:0 publications
Grant number: 477294
Grant search
Key facts
Disease
COVID-19Start & end year
2022Known Financial Commitments (USD)
$73,103.45Funder
Canadian Institutes of Health Research (CIHR)Principal Investigator
Raught BrianResearch Location
CanadaLead Research Institution
Princess Margaret Cancer Centre (Toronto)Research Priority Alignment
N/A
Research Category
Pathogen: natural history, transmission and diagnosticsResearch Subcategory
Pathogen morphology, shedding & natural historySpecial Interest Tags
N/AStudy Type
Non-ClinicalClinical Trial Details
N/ABroad Policy Alignment
PendingAge Group
Not ApplicableVulnerable Population
Not applicableOccupations of Interest
Not applicable
Abstract
Each cell in the human body is organized into distinct subcompartments called organelles. Organelles compartmentalize and organize specific groups of proteins to perform unique biological functions (e.g. protein synthesis, protein folding, or the synthesis, storage or breakdown of fatty acids). When a virus infects a cell, it can "reprogram" the host cell organelle machinery - essentially remodelling the host cell to create a highly efficient "virus factory". Our project aims to shed light on how human organelles are reprogrammed and remodeled in response to infection by the coronavirus SARS-CoV-2. We have developed highly specialized methods to track protein localization in living human cells (BioID Cell Mapping), and will use this technology to monitor a number of human organellar proteins in SARS-CoV-2 infected and uninfected cells. This work will provide much needed knowledge on how cellular organelles are remodeled in response to coronavirus infection, and identify new therapeutic targets for the treatment of viral infections.